CATALOGO DEI PRODOTTI DELLA RICERCA

PERTILE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.999
EU - Europa 2.901
AS - Asia 1.702
SA - Sud America 229
AF - Africa 71
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.947
RU - Federazione Russa 950
SG - Singapore 671
IT - Italia 569
GB - Regno Unito 538
CN - Cina 478
BR - Brasile 193
DE - Germania 178
FR - Francia 166
HK - Hong Kong 160
VN - Vietnam 134
IE - Irlanda 122
SE - Svezia 121
FI - Finlandia 98
KR - Corea 62
BD - Bangladesh 49
IN - India 31
CA - Canada 28
UA - Ucraina 27
ES - Italia 20
NL - Olanda 20
JP - Giappone 19
BE - Belgio 18
PL - Polonia 18
TR - Turchia 15
ID - Indonesia 13
AU - Australia 11
EC - Ecuador 10
MX - Messico 10
NG - Nigeria 10
SA - Arabia Saudita 10
ZA - Sudafrica 10
IQ - Iraq 9
PT - Portogallo 9
TG - Togo 9
AR - Argentina 8
AT - Austria 8
EG - Egitto 7
IR - Iran 7
PK - Pakistan 7
BJ - Benin 6
CO - Colombia 6
CZ - Repubblica Ceca 6
MA - Marocco 6
TN - Tunisia 6
GR - Grecia 5
NO - Norvegia 5
CL - Cile 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LT - Lituania 4
TW - Taiwan 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
IL - Israele 2
JM - Giamaica 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MR - Mauritania 1
MT - Malta 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.913
Salva come PNG Salva come JPEG
Città #
Southend 437
Singapore 363
Ashburn 331
Dallas 318
San Jose 317
Moscow 310
Chandler 308
Woodbridge 198
Ann Arbor 166
Verona 165
Jacksonville 163
Hong Kong 155
Dublin 115
Council Bluffs 80
The Dalles 77
Los Angeles 67
Beijing 65
Milan 58
Padova 56
New York 51
Princeton 46
Lawrence 44
Munich 43
Wilmington 41
Houston 39
Ho Chi Minh City 36
Helsinki 35
Nanjing 31
Hanoi 29
Shenyang 28
Buffalo 27
Tianjin 26
Jinan 25
São Paulo 23
Frankfurt am Main 20
Boardman 18
Orem 18
Santa Clara 18
Tokyo 18
Warsaw 18
Zhengzhou 16
Brussels 15
Guangzhou 15
Montreal 15
Columbus 14
Hebei 14
Lancaster 14
Rome 14
London 13
Sindelfingen 13
Taiyuan 13
Chennai 12
Phoenix 12
Redondo Beach 12
Stockholm 12
Haikou 11
Hangzhou 11
Seattle 11
Falkenstein 10
Ningbo 10
San Francisco 10
Denver 9
Jakarta 9
Jiaxing 9
Lomé 9
Norwalk 9
Redmond 9
Roverbella 9
Taizhou 9
Abuja 8
Atlanta 8
Changsha 8
Chicago 8
Manchester 8
Afragola 7
Ankara 7
Boston 7
Brooklyn 7
Da Nang 7
Dong Ket 7
Haiphong 7
Meda 7
Nanchang 7
Poplar 7
Riyadh 7
Amsterdam 6
Bari 6
Belluno 6
Belo Horizonte 6
Biên Hòa 6
Cotonou 6
Johannesburg 6
Lanzhou 6
Limena 6
Lonigo 6
Melbourne 6
Romola 6
Venice 6
Washington 6
Ballyvaghan 5
Totale 4.928
Salva come PNG Salva come JPEG
Nome #
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 265
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 257
A Large Scale OLG Model for the Analysis of the Redistributive Effects of Policy Reforms 247
R&D and market size: who benefits from orphan drug regulation? 231
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 220
Public policies over the life cycle: a large scale OLG model for France, Italy and Sweden 214
A large scale OLG model for France, Italy and Sweden: assessing the interpersonal and intrapersonal redistributive effects of public policies 204
Redistribution at the Local Level: The Case of Public Childcare in Italy. University of Verona Department of Economics Working Paper 21/2013 (ISSN 2036-2919) 190
Investimenti pubblici, risorse scarse: il ruolo dei diversi metodi di supporto alle decisioni 186
Redistribution at the Local Level: The Case of Public Childcare in Italy 186
L'ISEE in Italia: una nota metodologica partendo dai dati EU-SILC. University of Verona Department of Economics Working Paper 6/2014 (ISSN 2036-2919) 179
DRGs: the link between investment in technologies and appropriateness. WP Series University of Verona Department of Economics (ISSN 2036-2919), 31/2012 178
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 175
A stepped-wedge randomised controlled trial to assess efficacy and cost-effectiveness of a care-bundle to prevent falls in older hospitalised patients 168
Drug Prices and Incentives to Innovation by the Pharmaceutical Industry 167
Dynamic, economic approaches to HTA under uncertainty. WP Series University of Verona Department of Economics (ISSN 2036-2919), 03/2011 165
Job Sick Leave: Detecting Opportunistic Behavior 163
Public finance consolidation and fairness across living generations: the case of Italy. WP Series University of Verona Department of Economics (ISSN 2036-2919), 04/2012 162
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 155
Improving access to medicines and promoting pharmaceutical innovation 152
Efficienza e sostenibilità dell’intervento pubblico 150
The dynamics of pharmaceutical regulation and R&D investments. WP Series University of Verona Department of Economics (ISSN 2036-2919), 4/2012 149
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 149
A reply to "Who would benefit from average value-based pricing?" 145
Dynamic, incentive-compatible contracting for health services 142
The timing of adoption of positron emission tomography:a real options approach 141
An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography 140
The fiscal disadvantage of young italians: a new view on consolidation and fairness 140
Two-part payments for the reimbursement of investments in health technologies 138
Optimal sequential sampling rules for the economic evaluation of health technologies 135
Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial 135
Investment in health technologies in a competitive model with real options 134
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy 134
Strategic Interaction in Pharmaceutical Price Regulation: With or Without U? 133
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition" 133
The dynamics of pharmaceutical regulation and R&D investments 131
Which valued-based price when patients are heterogeneous? 131
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 129
Who should monitor job sick leave? 124
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 122
Technology adoption, quality and health care costs: a review of the literature 121
Optimal Decision Rules for HTA Under Uncertainty: a Wider, Dynamic Perspective 121
The impact of managed entry agreements on pharmaceutical prices 121
Optimal Bayesian sequential sampling rules for the economic evaluation of health technologies 120
Pricing policies when patients are heterogeneous: a welfare analysis 119
R&D and market size: who benefits from orphan drug legislation? 118
Static and dynamic effciency of irreversible health care investments under alternative payment rules 113
L’equità intergenerazionale delle politiche di bilancio 107
Static and Dynamic Efficiency of Irreversible Health Care investments under Alternative Payment Rules 102
Public health interventions: evaluating the economic evaluations 102
Valutare l’efficienza dei servizi ospedalieri in Italia: il caso delle aziende ospedaliero-universitarie 90
Optimal Sequential Sampling with Delayed Observations and Unknown Variance 84
Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition 79
Totale 7.996
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.299
article - articoli 13.036
book - libri 0
conference - conferenze 403
curatela - curatele 488
other - altro 9.587
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.785
Totale 50.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022422 30 70 13 6 19 17 18 25 41 13 66 104
2022/2023804 60 96 72 122 76 194 7 53 84 12 24 4
2023/2024435 18 30 31 72 47 57 27 38 10 16 53 36
2024/20251.183 57 90 67 195 32 32 31 102 162 82 103 230
2025/20263.547 218 177 331 568 833 206 374 183 252 210 68 127
Totale 7.996